Total Funding
26
57
Total FundingConvertible Note raised
Growth Score
-1 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
77215
OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
- Majid Anderesi: Vice President of Clinical and Medical Affairs
William Koster: Director
About the Company
OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.
